Christopher D. Leach

FDA investigator

Appears on 11 documents from 2013 to 2018, mostly at sites in Illinois. Most often cites design and construction features (21 CFR 211.42).

11
Documents on file
4.6
Observations per 483
2013
First seen
2018
Most recent

What they cite most

From 51 observations

Activity by year

2013: 3, 2015: 2, 2016: 4, 2017: 1, 2018: 1

Where

Illinois 8 · Texas 3

Is Christopher D. Leach coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 Catalent Pharma Solutions, LLCJul 3, 2018 · Woodstock, Illinois
483 Snyder Mark Drugs Roselle, Inc. dba Mark Drugs PharmacyMay 22, 2017 · Roselle, Illinois
483 Option CareSep 21, 2016 · Wood Dale, Illinois
483 Sage Products Inc 'Sep 1, 2016 · Cary, Illinois
483 Xttrium Laboratories, IncJul 11, 2016 · Mount Prospect, Illinois
483 PharMEDium Services LLCJan 4, 2016 · Lake Forest, Illinois
483 Fresenius Kabi USA LLCSep 1, 2015 · Melrose Park, Illinois

About this profile

What does Christopher D. Leach inspect?

Christopher D. Leach appears on 11 documents on file covering 11 sites, mostly in Illinois.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.166.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Christopher D. Leach is dated Jul 3, 2018.